Search tool

Displaying 1 - 6 of 6

Document library

Quality assurance in drug demand reduction in European countries: an overview

This article examines the evidence for quality assurance systems for drugs-related interventions in Europe, based on information gathered by the EMCDDA.

Close-up of virus

New EMCDDA report shows grounds for hope in treating hepatitis C

Hepatitis C is an infectious disease of the liver caused by the blood-borne hepatitis C virus. In a new report published today on World Hepatitis Day, the EU drugs agency (EMCDDA) looks...

Video thumbnail: NPS nightlife settings

Interview: Responses to new psychoactive substances in nightlife settings

Information on health responses to the use of new psychoactive substances (NPS) is emerging but, in many cases, remains anecdotal. To mark World Drugs Day 2016 on 26 June, we will be...

Video thumbnail: OST explained

Motion graphic: Opioid substitution treatment explained

The use of substitution drugs for the treatment of heroin dependence represents a key evidence-based response to heroin problems in Europe. The diversion of these medicines to non-medical use and sale on...

New EMCDDA insights into naloxone, the overdose antidote that can help save lives

Between 6 000 and 8 000 drug-induced deaths are reported in Europe every year, with opioids, such as heroin, found in most overdose cases. Yet with adequate intervention, using the overdose-reversal drug...

Publication thumbnail

Preventing opioid overdose deaths with take-home naloxone

This publication examines the case for distributing naloxone, an emergency medication, to people who inject opioids such as heroin and to others who might witness an opioid overdose. Through its capacity to...